Literature DB >> 33443646

Sleep Characteristics and Cerebrospinal Fluid Progranulin in Older Adults: The CABLE Study.

Meng Wang1, Fu-Rong Sun1, Yan-Lin Bi2, Ya-Hui Ma1, Jian-Jun Yin3, Xue-Ning Shen4, Xiao-Tong Wang1, Lan Tan5, Jin-Tai Yu6.   

Abstract

Cerebrospinal fluid (CSF) progranulin (PGRN) is related to various neurodegeneration diseases. And sleep problems can cause abnormality in protein metabolism in vivo. We aim to explore the potential associations between the self-reported sleep characteristics and CSF PGRN in cognitively intact older adults. Our study recruited 747 participants (mean (standard deviation (SD)) age, 61.99 (10.52) years, 329 (42.89%) females) who had normal cognition from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) study with CSF PGRN and sleep characteristics measured. The multiple linear regression and nonlinear regression adjusted for age, gender, education, and apolipoprotein E-epsilon 4 gene (APOE4) status were used to assess the associations between sleep characteristics and PGRN. Interaction effects were explored between APOE4 status and sleep characteristics on CSF PGRN level. Sleep disturbances indicated lower CSF PGRN (β = - 0.0186, p = 0.0160). For detailed items in sleep disturbances, lower CSF PGRN was found in males who woke up during sleep (β = - 0.0121, p = 0.0062) and in females who had breathing difficulties (β = - 0.0258, p = 0.0271). Meanwhile, sleep efficiency was associated with CSF PGRN (β = - 0.0512, p = 0.0497). No significant interaction effects between sleep characteristics and APOE4 status were found. Meanwhile, we did not find a nonlinear relationship between nocturnal sleep duration and CSF PGRN. Sleep problems may influence the metabolism of PGRN, thus attenuating the protective effects of PGRN on neurodegeneration diseases.

Entities:  

Keywords:  Alzheimer’s disease; Cerebrospinal fluid; Frontotemporal dementia; Progranulin; Sleep

Year:  2021        PMID: 33443646     DOI: 10.1007/s12640-020-00326-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  46 in total

Review 1.  Sleep Duration in Relation to Cognitive Function among Older Adults: A Systematic Review of Observational Studies.

Authors:  Elizabeth E Devore; Francine Grodstein; Eva S Schernhammer
Journal:  Neuroepidemiology       Date:  2016-01-07       Impact factor: 3.282

Review 2.  Memory consolidation in sleep disorders.

Authors:  Nicola Cellini
Journal:  Sleep Med Rev       Date:  2016-09-25       Impact factor: 11.609

Review 3.  The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.

Authors:  Erin L Boespflug; Jeffrey J Iliff
Journal:  Biol Psychiatry       Date:  2017-12-07       Impact factor: 13.382

4.  Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.

Authors:  Dong-Wan Chen; Jun Wang; Li-Li Zhang; Yan-Jiang Wang; Chang-Yue Gao
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Frontotemporal dementia.

Authors:  Jessica Deleon; Bruce L Miller
Journal:  Handb Clin Neurol       Date:  2018

6.  Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses.

Authors:  Ralph H B Benedict; Davorka Tomic; Bruce A Cree; Robert Fox; Gavin Giovannoni; Amit Bar-Or; Ralf Gold; Patrick Vermersch; Harald Pohlmann; Ian Wright; Göril Karlsson; Frank Dahlke; Christian Wolf; Ludwig Kappos
Journal:  Neurology       Date:  2020-12-16       Impact factor: 9.910

Review 7.  Neuroinflammation in frontotemporal dementia.

Authors:  Fiona Bright; Eryn L Werry; Carol Dobson-Stone; Olivier Piguet; Lars M Ittner; Glenda M Halliday; John R Hodges; Matthew C Kiernan; Clement T Loy; Michael Kassiou; Jillian J Kril
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

8.  Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep.

Authors:  Johann Daxer; Theresa Herttrich; Ying Y Zhao; Mandy Vogel; Andreas Hiemisch; Kathrin Scheuermann; Antje Körner; Jürgen Kratzsch; Wieland Kiess; Mirja Quante
Journal:  J Pediatr Endocrinol Metab       Date:  2017-01-01       Impact factor: 1.634

9.  Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial.

Authors:  Judith E Carroll; Teresa E Seeman; Richard Olmstead; Gerson Melendez; Ryan Sadakane; Richard Bootzin; Perry Nicassio; Michael R Irwin
Journal:  Psychoneuroendocrinology       Date:  2015-02-25       Impact factor: 4.905

Review 10.  Biomarkers of dementia in obstructive sleep apnea.

Authors:  Andrée-Ann Baril; Julie Carrier; Alexandre Lafrenière; Simon Warby; Judes Poirier; Ricardo S Osorio; Najib Ayas; Marie-Pierre Dubé; Dominique Petit; Nadia Gosselin
Journal:  Sleep Med Rev       Date:  2018-08-13       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.